Probiotics and prevention of neonatal necrotizing enterocolitis

Current Opinion in Pediatrics

Volumn 23, Issue 2, 2011, Pages 151-155

  Frost, Brandy L ^a   Caplan, Michael S ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

bacterial colonization; necrotizing enterocolitis; prematurity; probiotics

Indexed keywords

PROBIOTIC AGENT;

ARTIFICIAL MILK; BACTERIAL COLONIZATION; DRUG MECHANISM; HIGH RISK INFANT; HUMAN; NECROTIZING ENTEROCOLITIS; PATHOGENESIS; PATHOPHYSIOLOGY; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY CONTROL; REVIEW;

ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PROBIOTICS;

EID: 79954422514     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328343d65f     Document Type: Review

References (29)

1. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990; 336:1519-1523.
2. Tarnow-Mordi WO, Wilkinson D, Trivedi A, Brok J. Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice. Pediatrics 2010; 125:1068-1070. A recent editorial encouraging use of probiotics for preterm infants, and providing parents with current evidence for use.
3. Soll RF. Probiotics: are we ready for routine use? Pediatrics 2010; 125:1071-1072. A recent editorial that urges further study prior to routine probiotic use for preterm infants.
4. Abreu MT, Vora P, Faure E, et al. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 2001; 167:1609-1616. (Pubitemid 32703162)
5. Melmed G, Thomas LS, Lee N, et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 2003; 170:1406-1415. (Pubitemid 36139508)
6. Lotz M, Gutle D, Walther S, et al. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 2006; 203:973-984.
7. Jilling T, Simon D, Lu J, et al. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol 2006; 177:3273-3282. (Pubitemid 44277847)
8. Gribar SC, Sodhi CP, Richardson WM, et al. Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol 2009; 182:636-646. This recent study demonstrates that TLR4 and TLR9 may act in a counter-regulatory mechanism in NEC pathogenesis.
9. Caplan MS, Sun XM, Hseuh W, Hageman JR. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990; 116:960-964. (Pubitemid 20201711)
10. Amer MD, Hedlund E, Rochester J, Caplan MS. Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. Biol Neonate 2004; 85:159-166. (Pubitemid 38437696)
11. Caplan M, Hsueh W, Kelly A, Donovan M. Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins 1990; 39:705-714. (Pubitemid 20189833)
12. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999; 3:197-202.
13. Dani C, Biadaioli R, Bertini G, et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82:103-108.
14. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115:1-4.
15. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147:192-196. (Pubitemid 41207832)
16. Lin HC, Hsu CH, Chen HL, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008; 122:693-700.
17. Samanta M, Sarkar M,Ghosh P, et al. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 2009; 55:128-131. This study, conducted in India, used prophylactic probiotics for VLBW infants and found a reduction in NEC, death, and culture proven sepsis, as well as reduction in time to full enteral feeds and hospital stay, which was not reported in previous studies.
18. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010; 125:921-930. This meta-analysis evaluated 11 trials using probiotics for preterm infants and found significant reductions in NEC and death. The authors encourage routine use of probiotics in this population.
19. Alfaleh K, Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2008:CD005496.
20. Land MH, Rouster-Stevens K, Woods CR, et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115:178-181. (Pubitemid 43046298)
21. Ohishi A, Takahashi S, Ito Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr 2010; 156:679-681.
22. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004; 38:457-458.
23. Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:1019-1021. (Pubitemid 46527807)
24. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007; 119:184-191. (Pubitemid 46037800)
25. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:651-659.
26. Pagnini C, Saeed R, Bamias G, et al. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci USA 2010; 107:454-459.
27. Marcobal A, Underwood MA, Mills DA. Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis. J Pediatr Gastroenterol Nutr 2008; 46:608-611.
28. Reid G. The importance of guidelines in the development and application of probiotics. Curr Pharmaceut Des 2005; 11:11-16. (Pubitemid 40103624)
29. Hoffman FA, Heimbach JT, Sanders ME, Hibberd PL. Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs. Clin Infect Dis 2008; 46 (Suppl. 2):S53-S57. (Pubitemid 351323665)